Your browser doesn't support javascript.
loading
Extranucleolar CYCLON Staining Pattern Is Strongly Associated to Relapse/Refractory Disease in R-CHOP-treated DLBCL.
Bouroumeau, Antonin; Bussot, Lucile; Sartelet, Hervé; Fournier, Cyril; Betton-Fraisse, Patricia; Col, Edwige; David-Boudet, Laurence; McLeer, Anne; Lefebvre, Christine; Raskovalova, Tatiana; Jacob, Marie-Christine; Vettier, Claire; Chevalier, Simon; Algrin, Caroline; Carras, Sylvain; Gressin, Rémy; Callanan, Mary B; Bonnefoix, Thierry; Emadali, Anouk.
Afiliación
  • Bouroumeau A; Department of Cytology and Pathology, Grenoble-Alpes University Hospital, Grenoble, France.
  • Bussot L; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France.
  • Sartelet H; Department of Clinical Hematology, Grenoble-Alpes University Hospital, Grenoble, France.
  • Fournier C; Department of Cytology and Pathology, Grenoble-Alpes University Hospital, Grenoble, France.
  • Betton-Fraisse P; Unit for Innovation in Genetics and Epigenetics in Oncology and Dijon University Hospital, University of Bourgogne, INSERM 1231, Dijon, France.
  • Col E; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France.
  • David-Boudet L; Department of Cytology and Pathology, Grenoble-Alpes University Hospital, Grenoble, France.
  • McLeer A; Department of Cytology and Pathology, Grenoble-Alpes University Hospital, Grenoble, France.
  • Lefebvre C; Department of Cytology and Pathology, Grenoble-Alpes University Hospital, Grenoble, France.
  • Raskovalova T; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France.
  • Jacob MC; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France.
  • Vettier C; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France.
  • Chevalier S; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France.
  • Algrin C; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France.
  • Carras S; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France.
  • Gressin R; Hematology, Oncogenetics and Immunology Unit, Grenoble-Alpes University Hospital, Grenoble, France.
  • Callanan MB; Daniel Hollard Institute, Grenoble, France.
  • Bonnefoix T; Institute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309/Grenoble Alpes University, Grenoble, France.
  • Emadali A; Department of Clinical Hematology, Grenoble-Alpes University Hospital, Grenoble, France.
Hemasphere ; 5(7): e598, 2021 Jul.
Article en En | MEDLINE | ID: mdl-34131636
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Hemasphere Año: 2021 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Hemasphere Año: 2021 Tipo del documento: Article País de afiliación: Francia